Lipid Metabolism — MCQs
On this page
Glycerol is the backbone of all of the following phospholipids EXCEPT?
Prostaglandins are derived from:
A young man presents for a physical exam concerned about his family history of premature heart attacks. His father died of a heart attack in his late 40s. The patient has elevated serum cholesterol and LDL levels, with normal VLDL and triglycerides. Further investigation reveals an LDL receptor deficiency. Which type of hyperlipidemia does this patient have?
Beta-oxidation of fatty acids occurring in peroxisomes is differentiated from that occurring in mitochondria by which of the following?
What is the number of double bonds in arachidonic acid?
What is the only part of an odd-chain fatty acid that is glucogenic?
How are long-chain fatty acids transported across the inner mitochondrial membrane?
Which blood protein is involved in the transport of free fatty acids in the blood?
Which of the following factors in bile juice is responsible for preventing the precipitation of cholesterol and formation of gallstones?
What is the common precursor of mineralocorticoids, glucocorticoids, and sex steroids?
Lipid Metabolism Indian Medical PG Practice Questions and MCQs
Question 251: Glycerol is the backbone of all of the following phospholipids EXCEPT?
- A. Phosphatidylethanolamine
- B. Cardiolipin
- C. Phosphatidylcholine
- D. Sphingomyelin (Correct Answer)
Explanation: ### Explanation The core concept tested here is the structural classification of phospholipids. Phospholipids are divided into two main categories based on their alcohol backbone: **Glycerophospholipids** (glycerol backbone) and **Sphingophospholipids** (sphingosine backbone). **Why Sphingomyelin is the Correct Answer:** Sphingomyelin is the only human phospholipid that is **not** a glycerophospholipid. Instead of glycerol, it contains **sphingosine**, an 18-carbon amino alcohol. A fatty acid is attached to the amino group of sphingosine to form a **ceramide**, and a phosphorylcholine group is attached to the primary hydroxyl group. Therefore, it lacks a glycerol backbone. **Analysis of Incorrect Options:** * **A & C (Phosphatidylethanolamine & Phosphatidylcholine):** These are the most abundant glycerophospholipids in cell membranes. They consist of a glycerol-3-phosphate backbone esterified with two fatty acids and a nitrogenous base (ethanolamine or choline). * **B (Cardiolipin):** Also known as diphosphatidylglycerol, it consists of two molecules of phosphatidic acid linked by a **glycerol** bridge. It is unique to the inner mitochondrial membrane. **NEET-PG High-Yield Pearls:** * **Sphingomyelinase Deficiency:** Leads to **Niemann-Pick Disease**, characterized by hepatosplenomegaly and "cherry-red spots" on the macula. * **Cardiolipin Clinical Link:** It is the antigen used in the **VDRL test** for Syphilis. Antibodies against it (Anti-cardiolipin antibodies) are seen in **Antiphospholipid Syndrome (APS)**. * **Dipalmitoylphosphatidylcholine (DPPC):** Also known as Lecithin, it is the major constituent of **lung surfactant**. A Lecithin/Sphingomyelin (L/S) ratio > 2 in amniotic fluid indicates fetal lung maturity.
Question 252: Prostaglandins are derived from:
- A. Stearic acid
- B. Arachidonic acid (Correct Answer)
- C. Glutamic acid
- D. Aspartic acid
Explanation: **Explanation:** Prostaglandins belong to a group of biologically active lipid compounds called **Eicosanoids** (20-carbon fatty acids). They are synthesized from **Arachidonic acid**, a polyunsaturated fatty acid (PUFA) containing 20 carbons and four double bonds (C20:4, ω-6). 1. **Why Arachidonic acid is correct:** Arachidonic acid is released from membrane phospholipids by the enzyme **Phospholipase A₂**. It then enters the **Cyclooxygenase (COX) pathway** to produce Prostaglandins, Prostacyclins, and Thromboxanes, or the **Lipoxygenase (LOX) pathway** to produce Leukotrienes. 2. **Why other options are incorrect:** * **Stearic acid:** A 18-carbon saturated fatty acid (C18:0). It does not have the double bonds or carbon length required for eicosanoid synthesis. * **Glutamic acid & Aspartic acid:** These are acidic amino acids involved in protein synthesis and the urea cycle, not lipid metabolism or prostaglandin synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting step:** The release of arachidonic acid by **Phospholipase A₂** is the rate-limiting step in prostaglandin synthesis. This enzyme is inhibited by **Corticosteroids** (via Annexin A1/Lipocortin). * **NSAIDs Mechanism:** Aspirin and other NSAIDs act by irreversibly or reversibly inhibiting **COX-1 and COX-2**, thereby blocking prostaglandin synthesis. * **Essential Fatty Acid Link:** Arachidonic acid is considered semi-essential; it can be synthesized from the essential fatty acid **Linoleic acid** (C18:2, ω-6). * **Prostaglandin E1 (Alprostadil):** Used clinically to keep the Ductus Arteriosus patent in neonates with cyanotic heart disease.
Question 253: A young man presents for a physical exam concerned about his family history of premature heart attacks. His father died of a heart attack in his late 40s. The patient has elevated serum cholesterol and LDL levels, with normal VLDL and triglycerides. Further investigation reveals an LDL receptor deficiency. Which type of hyperlipidemia does this patient have?
- A. Type I
- B. Type IIa (Correct Answer)
- C. Type IIb
- D. Type III
Explanation: **Explanation:** The patient presents with a classic case of **Familial Hypercholesterolemia (Type IIa Hyperlipoproteinemia)**. This condition is characterized by a genetic deficiency or defect in the **LDL receptors**, leading to impaired clearance of LDL from the plasma. **Why Type IIa is correct:** In Type IIa, there is a selective elevation of **Low-Density Lipoprotein (LDL)**. Since LDL is the primary carrier of cholesterol, the lipid profile shows significantly elevated serum cholesterol with **normal triglycerides and VLDL**. The clinical history of premature coronary artery disease (CAD) and autosomal dominant inheritance (suggested by the father’s early death) are hallmark features. **Why other options are incorrect:** * **Type I (Familial Chylomicronemia):** Caused by a deficiency in Lipoprotein Lipase (LPL) or Apo C-II. It presents with severely elevated **Triglycerides** and Chylomicrons, not isolated cholesterol. * **Type IIb (Combined Hyperlipidemia):** Involves elevation of both **LDL and VLDL**. Consequently, both cholesterol and triglycerides are elevated, unlike this patient who has normal VLDL/Triglycerides. * **Type III (Dysbetalipoproteinemia):** Caused by **Apo E deficiency**, leading to the accumulation of IDL and Chylomicron remnants (Broad-beta band). Both cholesterol and triglycerides are typically elevated. **High-Yield NEET-PG Pearls:** * **Clinical Signs:** Look for **Xanthomas** (Tendon xanthoma is pathognomonic for Type II) and **Corneal arcus** at a young age. * **Friedewald Formula:** LDL = Total Cholesterol – [HDL + (TG/5)]. Note: This is invalid if TG >400 mg/dL. * **Statins** are the first-line treatment as they upregulate LDL receptor expression.
Question 254: Beta-oxidation of fatty acids occurring in peroxisomes is differentiated from that occurring in mitochondria by which of the following?
- A. Formation of Acetyl CoA
- B. Formation of H2O2 (Correct Answer)
- C. Presence of different enzymes in different sites
- D. Requirement of NADH
Explanation: **Explanation:** The primary difference between mitochondrial and peroxisomal beta-oxidation lies in the **initial step of the pathway**, specifically how electrons are transferred from the substrate. 1. **Why Option B is Correct:** In mitochondria, the first step is catalyzed by *Acyl-CoA dehydrogenase*, which transfers electrons to FAD, eventually entering the electron transport chain to produce ATP. In **peroxisomes**, the first step is catalyzed by **Acyl-CoA oxidase**. This enzyme transfers electrons directly to molecular oxygen ($O_2$), resulting in the formation of **Hydrogen Peroxide ($H_2O_2$)**. This $H_2O_2$ is subsequently degraded by the enzyme **catalase**. 2. **Why Other Options are Incorrect:** * **Option A:** Both pathways result in the production of **Acetyl CoA** (though peroxisomal oxidation stops at shorter chain lengths, usually octanoyl-CoA, which is then exported to mitochondria). * **Option C:** While it is true that different enzymes are used (e.g., bifunctional protein in peroxisomes), the question asks for the specific biochemical product that *differentiates* the two processes. $H_2O_2$ formation is the hallmark metabolic distinction. * **Option D:** Both pathways require $NAD^+$ and produce **NADH** during the 3-hydroxyacyl-CoA dehydrogenase step. **High-Yield NEET-PG Pearls:** * **Substrate Specificity:** Peroxisomes are specialized for the oxidation of **Very Long Chain Fatty Acids (VLCFA)** (C22 or longer) and branched-chain fatty acids (e.g., phytanic acid via alpha-oxidation). * **Energy Yield:** Peroxisomal oxidation is **less energy-efficient** because the first step bypasses the ETC, dissipating energy as heat rather than capturing it as ATP. * **Clinical Correlation:** Defects in peroxisomal beta-oxidation or biogenesis lead to **Zellweger Syndrome** (accumulation of VLCFA in the brain and liver) and **X-linked Adrenoleukodystrophy**.
Question 255: What is the number of double bonds in arachidonic acid?
- A. 1
- B. 2
- C. 3
- D. 4 (Correct Answer)
Explanation: **Explanation:** Arachidonic acid is a **20-carbon** polyunsaturated fatty acid (PUFA) belonging to the **Omega-6 (ω-6)** family. Its chemical notation is **20:4 (Δ5, 8, 11, 14)**, which indicates that it contains **4 double bonds** located at the 5th, 8th, 11th, and 14th carbon atoms. **Why Option D is Correct:** Arachidonic acid is synthesized from the essential fatty acid, linoleic acid. It serves as the primary precursor for the synthesis of **eicosanoids**, including prostaglandins, thromboxanes, and leukotrienes, via the cyclooxygenase (COX) and lipoxygenase (LOX) pathways. **Why Other Options are Incorrect:** * **Option A (1):** Represents monounsaturated fatty acids (MUFA) like **Oleic acid** (18:1). * **Option B (2):** Represents **Linoleic acid** (18:2), an essential ω-6 fatty acid. * **Option C (3):** Represents **α-Linolenic acid** (18:3), an essential ω-3 fatty acid. **High-Yield NEET-PG Pearls:** 1. **Essentiality:** Arachidonic acid becomes "essential" only if its precursor, linoleic acid, is deficient in the diet. 2. **Pro-inflammatory role:** Most eicosanoids derived from arachidonic acid (like PGE2 and LTB4) are mediators of inflammation. 3. **Membrane source:** It is typically esterified in membrane phospholipids at the **sn-2 position** and is released by the enzyme **Phospholipase A2**. 4. **Mnemonic:** Remember the "4" in the name "Arachidonic" (A-R-A-C) to recall the 4 double bonds.
Question 256: What is the only part of an odd-chain fatty acid that is glucogenic?
- A. Propionyl CoA (Correct Answer)
- B. Acetyl CoA
- C. Malonyl CoA
- D. Acyl CoA
Explanation: **Explanation:** In the metabolism of fatty acids, even-chain fatty acids undergo β-oxidation to produce **Acetyl CoA**, which enters the TCA cycle but cannot be used for net glucose synthesis (gluconeogenesis) because the two carbons lost as $CO_2$ in the cycle balance the two carbons entering. **Why Propionyl CoA is correct:** Odd-chain fatty acids undergo β-oxidation until a final three-carbon fragment remains: **Propionyl CoA**. This is the only part of the fatty acid that is glucogenic because it follows a specific three-step pathway: 1. **Propionyl CoA** is carboxylated to D-methylmalonyl CoA (requires **Biotin/B7**). 2. It is isomerized to L-methylmalonyl CoA. 3. L-methylmalonyl CoA is converted to **Succinyl CoA** (requires **Vitamin B12**). Succinyl CoA is a TCA cycle intermediate that can be converted to oxaloacetate and subsequently enter the gluconeogenic pathway to form glucose. **Why the other options are incorrect:** * **B. Acetyl CoA:** Produced by even-chain fatty acids; it cannot be converted back to pyruvate or oxaloacetate for net glucose synthesis in humans. * **C. Malonyl CoA:** An intermediate in fatty acid *synthesis* (lipogenesis) and a potent inhibitor of Carnitine Palmitoyltransferase-1 (CPT-1); it is not a product of β-oxidation. * **D. Acyl CoA:** This is a general term for a fatty acid attached to Coenzyme A at any stage of oxidation; it is not a specific glucogenic end-product. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin B12 Deficiency:** Leads to the accumulation of **Methylmalonic acid (MMA)** in urine, a specific diagnostic marker that distinguishes B12 deficiency from Folate deficiency. * **Enzyme Deficiency:** Propionic acidemia is caused by a deficiency of Propionyl CoA carboxylase. * **Mnemonic:** "Odd-chain fatty acids are the exception to the rule that fats don't make sugar."
Question 257: How are long-chain fatty acids transported across the inner mitochondrial membrane?
- A. Acyl carrier protein
- B. Acyl carnitine (Correct Answer)
- C. Simple diffusion
- D. Energy mediated transport
Explanation: ### Explanation **Correct Answer: B. Acyl carnitine** The inner mitochondrial membrane (IMM) is impermeable to long-chain fatty acids (LCFAs). To undergo beta-oxidation, LCFAs must be transported from the cytosol into the mitochondrial matrix via the **Carnitine Shuttle**. 1. **Activation:** LCFAs are first converted to Acyl-CoA in the cytosol. 2. **Transesterification:** The enzyme **Carnitine Palmitoyltransferase-I (CPT-I)**, located on the outer membrane, converts Acyl-CoA into **Acyl carnitine**. 3. **Translocation:** Acyl carnitine is then shuttled across the IMM by *Carnitine-acylcarnitine translocase*. 4. **Reconversion:** Once inside the matrix, **CPT-II** converts Acyl carnitine back into Acyl-CoA and free carnitine. **Analysis of Incorrect Options:** * **A. Acyl carrier protein (ACP):** This is a key component of the **Fatty Acid Synthase complex** used in fatty acid *synthesis* (cytosol), not degradation (mitochondria). * **C. Simple diffusion:** Only short-chain (C2–C4) and medium-chain (C6–C12) fatty acids can cross the mitochondrial membranes via simple diffusion. * **D. Energy mediated transport:** While the initial activation of fatty acids requires ATP, the actual movement across the IMM is a facilitated exchange (antiport) driven by the concentration gradient of carnitine, not direct primary active transport. **NEET-PG High-Yield Pearls:** * **Rate-limiting step:** CPT-I is the rate-limiting enzyme of beta-oxidation. * **Inhibitor:** **Malonyl-CoA** (the first intermediate of FA synthesis) inhibits CPT-I, preventing a "futile cycle" where synthesis and degradation occur simultaneously. * **Clinical Correlation:** **Systemic Carnitine Deficiency** presents with non-ketotic hypoglycemia, as the liver cannot oxidize fats to produce energy or ketone bodies during fasting.
Question 258: Which blood protein is involved in the transport of free fatty acids in the blood?
- A. Albumin (Correct Answer)
- B. Globulin
- C. Fibrinogen
- D. Carnitine
Explanation: **Explanation:** **Correct Answer: A. Albumin** Free fatty acids (FFAs), also known as non-esterified fatty acids (NEFA), are hydrophobic molecules released from adipose tissue via lipolysis. Because they are insoluble in water, they cannot travel freely in the plasma. **Albumin** acts as the primary carrier protein for FFAs in the blood. It possesses multiple high-affinity binding sites (hydrophobic pockets) that allow it to transport up to 7–10 fatty acid molecules simultaneously, preventing them from forming toxic aggregates or damaging cell membranes. **Analysis of Incorrect Options:** * **B. Globulin:** While globulins transport specific lipids (e.g., steroid hormones via SHBG) and ions, they are not the primary transporters for free fatty acids. * **C. Fibrinogen:** This is a high-molecular-weight plasma protein essential for blood coagulation (clotting) and does not play a role in lipid transport. * **D. Carnitine:** This is a common distractor. Carnitine is involved in the transport of long-chain fatty acids **across the inner mitochondrial membrane** (the "Carnitine Shuttle") for beta-oxidation, but it is not a blood transport protein. **High-Yield Clinical Pearls for NEET-PG:** * **Lipid Transport Distinction:** Remember that while **Albumin** transports *free* fatty acids, **Lipoproteins** (Chylomicrons, VLDL, LDL, HDL) transport *esterified* lipids like triacylglycerols and cholesterol. * **Drug Binding:** Albumin also binds various acidic drugs (e.g., Warfarin, Phenytoin). In states of hypoalbuminemia, the free fraction of these drugs and fatty acids increases, potentially leading to toxicity. * **Energy Source:** FFAs are the preferred fuel source for the resting heart and skeletal muscle.
Question 259: Which of the following factors in bile juice is responsible for preventing the precipitation of cholesterol and formation of gallstones?
- A. High alkaline condition
- B. High concentration of bicarbonates
- C. Bile salts (Correct Answer)
- D. Bile pigments
Explanation: ### Explanation **Core Concept: Cholesterol Solubility in Bile** Cholesterol is a highly hydrophobic lipid that is virtually insoluble in water. In the gallbladder, it is kept in a soluble state through the formation of **mixed micelles**. These micelles are composed of **bile salts** and **phospholipids** (specifically lecithin). Bile salts are amphipathic molecules; they orient their hydrophobic faces toward cholesterol and their hydrophilic faces toward the aqueous environment of the bile. This prevents cholesterol from crystallizing and precipitating into gallstones (cholelithiasis). **Analysis of Options:** * **Bile salts (Correct):** They act as biological detergents. By increasing the "lithogenic index" (the ratio of cholesterol to bile salts/phospholipids), a deficiency in bile salts leads to supersaturation of bile and stone formation. * **High alkaline condition & Bicarbonates (Incorrect):** While bile is alkaline (due to ductal secretion of $HCO_3^-$) to neutralize gastric acid in the duodenum, pH does not play the primary role in cholesterol solubilization. * **Bile pigments (Incorrect):** Bile pigments (bilirubin) are waste products. While they can form "pigment stones" (calcium bilirubinate), they do not prevent cholesterol precipitation; in fact, excess bilirubin contributes to stone pathology. **High-Yield Clinical Pearls for NEET-PG:** * **The "Fair, Fat, Forty, Fertile, Female"** mnemonic describes the classic demographic for cholesterol gallstones. * **Lecithin:** Along with bile salts, lecithin is the primary phospholipid that aids cholesterol solubility. * **Bile Acid Sequestrants (e.g., Cholestyramine):** These can theoretically increase the risk of gallstones by depleting the bile acid pool. * **Rate-limiting enzyme:** Cholesterol 7$\alpha$-hydroxylase is the key enzyme in bile acid synthesis; its inhibition leads to decreased bile salt production.
Question 260: What is the common precursor of mineralocorticoids, glucocorticoids, and sex steroids?
- A. Pregnenolone (Correct Answer)
- B. alpha-hydroxyprogesterone
- C. Dehydrotestosterone
- D. Deoxycortisol
Explanation: **Explanation:** The synthesis of all steroid hormones (steroidogenesis) begins with **cholesterol**. The first and rate-limiting step occurs in the mitochondria, where the enzyme **Cholesterol side-chain cleavage enzyme (P450scc/Desmolase)** converts cholesterol into **Pregnenolone**. Pregnenolone serves as the "master precursor" or the common trunk of the steroidogenic pathway. From Pregnenolone, the pathway branches out to produce: 1. **Mineralocorticoids** (e.g., Aldosterone) via Progesterone. 2. **Glucocorticoids** (e.g., Cortisol) via 17-hydroxypregnenolone. 3. **Sex Steroids** (e.g., Testosterone, Estrogen) via Dehydroepiandrosterone (DHEA). **Analysis of Incorrect Options:** * **B. 17-alpha-hydroxyprogesterone:** This is an intermediate specifically involved in the synthesis of glucocorticoids and sex steroids, but it is formed *after* pregnenolone. * **C. Dehydrotestosterone (DHT):** This is a potent androgen derived from testosterone via the action of 5-alpha-reductase; it is a terminal product, not a common precursor. * **D. 11-Deoxycortisol:** This is a direct precursor to cortisol in the glucocorticoid pathway, formed by the action of 21-hydroxylase. **High-Yield NEET-PG Pearls:** * **Rate-limiting step:** Conversion of Cholesterol to Pregnenolone by **Desmolase**. This step is stimulated by ACTH in the adrenal cortex and LH in the gonads. * **StAR Protein:** The Steroidogenic Acute Regulatory (StAR) protein is responsible for transporting cholesterol into the mitochondria; its deficiency leads to Congenital Lipoid Adrenal Hyperplasia. * **Congenital Adrenal Hyperplasia (CAH):** The most common enzyme deficiency is **21-hydroxylase**, which leads to a buildup of 17-hydroxyprogesterone and shunting of precursors toward androgen synthesis (virilization).
Practice by Chapter
Lipid Classification and Chemistry
Practice Questions
Fatty Acid Oxidation
Practice Questions
Ketone Body Metabolism
Practice Questions
Fatty Acid Synthesis
Practice Questions
Metabolism of Triacylglycerols
Practice Questions
Phospholipid Metabolism
Practice Questions
Cholesterol Metabolism and Biosynthesis
Practice Questions
Bile Acids and Bile Salts
Practice Questions
Lipoprotein Metabolism and Transport
Practice Questions
Dyslipidemias and Atherosclerosis
Practice Questions
Prostaglandins and Eicosanoids
Practice Questions
Fatty Liver and Lipotropic Factors
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free